Jefferies Raises Price Target on UnitedHealth Group (UNH), Maintains Hold Rating
Get Alerts UNH Hot Sheet
Price: $487.30 --0%
Rating Summary:
28 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 5 | New: 2
Rating Summary:
28 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 5 | New: 2
Join SI Premium – FREE
Jefferies is maintaining its Hold rating on shares of UnitedHealth Group (NYSE: UNH) and is raising its price target from $41 to $48.
The firm reports that Health Net, Inc. (NYSE: HNT), Humana Inc. (NYSE: HUM), and HealthSpring, Inc (NYSE: HS) is its top picks for posting an upside in Q1.
Currently in the market utilization trends are flat-ish, and unit pricing remains in-check. The firm notes that cost trends may be returning to more normal levels, evidence suggests MLRs could run below guidance for Q1.
With earnings being positively related with MLR changes, Jefferies is assuming a 50bps reduction in Q1 MLR for each company in the market. The firm now believes that HNT, HUM, and HS will post its Q1 results with a 12-13% upside of the streets estimates, while Aetna Inc. (NYSE: AET), Coventry Health Care (NYSE: CVH), UnitedHealth Group Inc. (NYSE: UNH), and WellPoint (NYSE: WLP) should post an upside of 6-7%. Jefferies thinks that CIGNA's Corp. (NYSE: CI) results will only top the Streets by 3%.
HNT, HUM, and HS all stand to benefit the most from a 50 bps lower MLR since they have a lower proportion of earnings from investment income and other non-risk health insurance premiums. The firm believes that the market has not fully reflected the Q1 potential EPS upside for the companies as the Streets FY12 estimates are 4.5% higher than the guidance for the MCO group.
The firm comments that, "An unfavorable RADV methodology decision by CMS is still a risk on investors' minds, and would be most harmful to HS, HUM, and UNH. CMS has given no indication of an update, but we suspect a decision in the next month or two that is milder than the draft language."
For more ratings news on UnitedHealth Group click here and for the rating history of UnitedHealth Group click here.
Shares of UnitedHealth Group closed at $44.33 yesterday.
The firm reports that Health Net, Inc. (NYSE: HNT), Humana Inc. (NYSE: HUM), and HealthSpring, Inc (NYSE: HS) is its top picks for posting an upside in Q1.
Currently in the market utilization trends are flat-ish, and unit pricing remains in-check. The firm notes that cost trends may be returning to more normal levels, evidence suggests MLRs could run below guidance for Q1.
With earnings being positively related with MLR changes, Jefferies is assuming a 50bps reduction in Q1 MLR for each company in the market. The firm now believes that HNT, HUM, and HS will post its Q1 results with a 12-13% upside of the streets estimates, while Aetna Inc. (NYSE: AET), Coventry Health Care (NYSE: CVH), UnitedHealth Group Inc. (NYSE: UNH), and WellPoint (NYSE: WLP) should post an upside of 6-7%. Jefferies thinks that CIGNA's Corp. (NYSE: CI) results will only top the Streets by 3%.
HNT, HUM, and HS all stand to benefit the most from a 50 bps lower MLR since they have a lower proportion of earnings from investment income and other non-risk health insurance premiums. The firm believes that the market has not fully reflected the Q1 potential EPS upside for the companies as the Streets FY12 estimates are 4.5% higher than the guidance for the MCO group.
The firm comments that, "An unfavorable RADV methodology decision by CMS is still a risk on investors' minds, and would be most harmful to HS, HUM, and UNH. CMS has given no indication of an update, but we suspect a decision in the next month or two that is milder than the draft language."
For more ratings news on UnitedHealth Group click here and for the rating history of UnitedHealth Group click here.
Shares of UnitedHealth Group closed at $44.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
- JPMorgan Downgrades Monster Beverage (MNST) to Neutral, 'Cost Pressures and Weaker Low-end Consumer'
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & Co, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!